Prelude Capital Management’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.17M | Sell |
163,181
-6,268
| -4% | -$45K | 0.11% | 225 |
|
|
2025
Q1 | $1.02M | Buy |
+169,449
| New | +$1.02M | 0.08% | 253 |
|
|
2023
Q4 | – | Sell |
-27,100
| Closed | -$264K | – | 1031 |
|
|
2023
Q3 | $264K | Buy |
+27,100
| New | +$264K | 0.02% | 623 |
|
|
2023
Q2 | – | Sell |
-26,000
| Closed | -$281K | – | 1047 |
|
|
2023
Q1 | $281K | Buy |
+26,000
| New | +$281K | 0.02% | 598 |
|